These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 33982141)
1. Safety and tolerability of chronic intranasal oxytocin in older men: results from a randomized controlled trial. Rung JM; Horta M; Tammi EM; Perez E; Ojeda MC; Lin T; Harris G; Somerville J; Salmeron D; Beltz SE; Sandesara B; Feifel D; Ebner NC Psychopharmacology (Berl); 2021 Sep; 238(9):2405-2418. PubMed ID: 33982141 [TBL] [Abstract][Full Text] [Related]
2. Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up. Alaerts K; Steyaert J; Vanaudenaerde B; Wenderoth N; Bernaerts S Eur Neuropsychopharmacol; 2021 Feb; 43():147-152. PubMed ID: 33309460 [TBL] [Abstract][Full Text] [Related]
4. Effects of chronic intranasal oxytocin on visual attention to faces vs. natural scenes in older adults. Shoenfelt A; Pehlivanoglu D; Lin T; Ziaei M; Feifel D; Ebner NC Psychoneuroendocrinology; 2024 Jun; 164():107018. PubMed ID: 38461634 [TBL] [Abstract][Full Text] [Related]
5. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study. Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269 [TBL] [Abstract][Full Text] [Related]
6. Salivary Oxytocin Concentrations in Males following Intranasal Administration of Oxytocin: A Double-Blind, Cross-Over Study. Daughters K; Manstead AS; Hubble K; Rees A; Thapar A; van Goozen SH PLoS One; 2015; 10(12):e0145104. PubMed ID: 26669935 [TBL] [Abstract][Full Text] [Related]
7. Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration. Francis SM; Kirkpatrick MG; de Wit H; Jacob S Psychoneuroendocrinology; 2016 Dec; 74():92-100. PubMed ID: 27592327 [TBL] [Abstract][Full Text] [Related]
8. Intranasal oxytocin in the treatment of anorexia nervosa: Randomized controlled trial during re-feeding. Russell J; Maguire S; Hunt GE; Kesby A; Suraev A; Stuart J; Booth J; McGregor IS Psychoneuroendocrinology; 2018 Jan; 87():83-92. PubMed ID: 29049935 [TBL] [Abstract][Full Text] [Related]
9. Effects of a 10-day oxytocin trial in older adults on health and well-being. Barraza JA; Grewal NS; Ropacki S; Perez P; Gonzalez A; Zak PJ Exp Clin Psychopharmacol; 2013 Apr; 21(2):85-92. PubMed ID: 23421352 [TBL] [Abstract][Full Text] [Related]
10. Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment. Quintana DS; Westlye LT; Rustan ØG; Tesli N; Poppy CL; Smevik H; Tesli M; Røine M; Mahmoud RA; Smerud KT; Djupesland PG; Andreassen OA Transl Psychiatry; 2015 Jul; 5(7):e602. PubMed ID: 26171983 [TBL] [Abstract][Full Text] [Related]
12. Oxytocin for frontotemporal dementia: a randomized dose-finding study of safety and tolerability. Finger EC; MacKinley J; Blair M; Oliver LD; Jesso S; Tartaglia MC; Borrie M; Wells J; Dziobek I; Pasternak S; Mitchell DG; Rankin K; Kertesz A; Boxer A Neurology; 2015 Jan; 84(2):174-81. PubMed ID: 25503617 [TBL] [Abstract][Full Text] [Related]
13. Protocol for a placebo-controlled, within-participants crossover trial evaluating the efficacy of intranasal oxytocin to improve pain and function among women with chronic pelvic musculoskeletal pain. Rash JA; Toivonen K; Robert M; Nasr-Esfahani M; Jarrell JF; Campbell TS BMJ Open; 2017 Apr; 7(4):e014909. PubMed ID: 28416501 [TBL] [Abstract][Full Text] [Related]
14. Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders. Tachibana M; Kagitani-Shimono K; Mohri I; Yamamoto T; Sanefuji W; Nakamura A; Oishi M; Kimura T; Onaka T; Ozono K; Taniike M J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):123-7. PubMed ID: 23480321 [TBL] [Abstract][Full Text] [Related]
15. Anxiolytic Effects of Chronic Intranasal Oxytocin on Neural Responses to Threat Are Dose-Frequency Dependent. Kou J; Zhang Y; Zhou F; Gao Z; Yao S; Zhao W; Li H; Lei Y; Gao S; Kendrick KM; Becker B Psychother Psychosom; 2022; 91(4):253-264. PubMed ID: 35086102 [TBL] [Abstract][Full Text] [Related]
16. The effects of intranasal oxytocin on reward circuitry responses in children with autism spectrum disorder. Greene RK; Spanos M; Alderman C; Walsh E; Bizzell J; Mosner MG; Kinard JL; Stuber GD; Chandrasekhar T; Politte LC; Sikich L; Dichter GS J Neurodev Disord; 2018 Mar; 10(1):12. PubMed ID: 29587625 [TBL] [Abstract][Full Text] [Related]
17. Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome. Hall SS; Lightbody AA; McCarthy BE; Parker KJ; Reiss AL Psychoneuroendocrinology; 2012 Apr; 37(4):509-18. PubMed ID: 21862226 [TBL] [Abstract][Full Text] [Related]
19. Effects of Intranasal Oxytocin on Stress-Induced Cigarette Craving in Daily Smokers. Van Hedger K; Bershad AK; Lee R; de Wit H Nicotine Tob Res; 2020 Jan; 22(1):89-95. PubMed ID: 30085292 [TBL] [Abstract][Full Text] [Related]